Research and society

Brain research in Rwanda: How do intergroup biases between former perpetrators and victims evolve after the genocide against Tutsi?

Emilie Caspar

Nearly 30 years ago, Rwanda went through a particularly brutal genocide perpetrated against Tutsis. The perpetrators were mainly regular citizens: colleagues, neighbours, family members… Today, both perpetrators and victims live side-by-side peacefully. But in a post-genocide society, can intergroup biases be ever reduced between individuals?

Read more

Human rights under threat from new technologies

Mensenrechten

Virtually all human rights treaties are much older than the modern technologies that determine the rhythm of our day-to-day lives. But these rights are under threat, especially from large tech companies. Professors Ruben Verborgh and Eva Lievens advocate an entirely new mindset: “The first step must always be to think about what kind of society we want. Only then can we build the technology necessary to achieve it, not the other way around.”

Read more

A legacy as a catalyst for the treatment of peritoneal cancer

Wim Ceelen

Few people have heard of it: peritoneal cancer. However, the disease, especially as a metastasis of another cancer, affects many patients. Unfortunately, it is often too late once the diagnosis is made: existing treatments achieve very little. Groundbreaking research by Professor Wim Ceelen is now resulting in new and promising treatments. And all thanks to the inheritance of a former patient.

Read more

Science or art? Researcher Kim creates unique tree scans

Lidart

Kim Calders discovered his passion for scanning trees when doing his PhD in Hallerbos forest, near Brussels. As a bio-engineer, he has been travelling the world with his LiDAR scanner ever since. Along the way, he has ended up face to face with cassowaries and elephants, and collaborated with artists to make a forest sing. A story in nine pictures.

Read more

opinion

Tapering off antidepressants no easy matter

Ellen Van Leeuwen
Ellen Van Leeuwen
Ellen Van Leeuwen is general practitioner and clinical pharmacologist

1.22 million Belgians take antidepressants daily. That’s more than 1 out of every 10 people in the entire population. What’s remarkable is that many continue to take the pills for years. Tapering off is recommended, but hardly any research has been done into how one best goes about it. General practitioner and clinical pharmacologist Ellen Van Leeuwen thinks there is an urgent need to invest in helping people discontinue the use of antidepressants.

Read more